No substitutes available
Darzalex Faspro 1800mg Injection contains Daratumumab, a targeted monoclonal antibody therapy used to treat multiple myeloma, a cancer of the bone marrow, in adults aged 18 years and above. Unlike traditional chemotherapy, this medicine works by helping the immune system identify and destroy cancer cells. Darzalex Faspro specifically targets a protein called CD38 found on multiple myeloma cells, leading to their destruction and slowing disease progression. It is commonly prescribed either alone or in combination with other anti-cancer medicines, depending on the stage of the disease and previous treatments.
This medication requires careful medical supervision as it can affect blood cell counts and may reactivate dormant infections such as hepatitis B. Patients receiving Darzalex Faspro are closely monitored for infusion-related reactions and changes in blood test results to ensure safe and effective treatment.
Darzalex Faspro 1800mg Injection is used for:
It may be prescribed as monotherapy or combined with other cancer treatments based on individual clinical needs.
Darzalex Faspro works by binding to CD38, a protein highly expressed on multiple myeloma cells. Once attached, it activates the immune system to destroy these cancer cells through multiple immune pathways. This targeted action helps reduce tumor burden, slow disease progression, and improve treatment response while minimizing damage to healthy cells.
Side Effects of Darzalex Faspro 1800mg Injection
Like all medications, Darzalex Faspro 1800mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Darzalex Faspro 1800mg Injection is administered only by a trained healthcare professional in a hospital or clinical setting. The dose, frequency, and duration of treatment are determined by the doctor based on disease severity, previous treatments, and overall health. Patients are monitored during and after administration for possible reactions. Self-administration is strictly not allowed.
The safety of Darzalex Faspro during breastfeeding has not been clearly established. Breastfeeding mothers should consult their doctor to carefully assess potential risks before starting or continuing treatment.
Alcohol consumption may increase the risk of drowsiness, fatigue, or other side effects while receiving Darzalex Faspro. It is advisable to limit or avoid alcohol and discuss safe consumption with your healthcare provider.
Inform your doctor if you have asthma, chronic obstructive pulmonary disease (COPD), or any other respiratory conditions, as Darzalex Faspro may increase the risk of breathing-related reactions.
This medicine may cause dizziness, fatigue, or reduced alertness. Avoid driving or operating heavy machinery until you know how your body responds to the treatment.
Darzalex Faspro should be used during pregnancy only if absolutely necessary, as it may cause harm to the unborn baby. Women of childbearing potential are advised to use effective contraception during treatment and continue it for at least 3 months after the final dose.
Darzalex Faspro is an immunotherapy, not chemotherapy. It targets the CD38 protein on multiple myeloma cells and activates the immune system to destroy cancer cells while minimizing damage to healthy cells.
Yes, Darzalex Faspro may be used as a first-line or subsequent treatment depending on disease stage, prior therapies, and overall patient health, as determined by the oncologist.
Yes. Darzalex Faspro can interfere with blood typing and cross-matching tests. Patients should inform healthcare providers and blood banks before receiving any blood transfusions.
Patients with past hepatitis B infection must inform their doctor before treatment, as Darzalex Faspro may reactivate the virus and requires close monitoring throughout therapy.
Yes. Darzalex Faspro may be used long-term under strict medical supervision. Treatment duration depends on response, tolerability, and disease progression, with regular follow-ups required.
| Active ingredient | Daratumumab |
| Pharmacologic class | Monoclonal Antibody |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Darzalex Faspro 1800mg Injection contains Daratumumab, a targeted monoclonal antibody therapy used to treat multiple myeloma, a cancer of the bone marrow, in adults aged 18 years and above. Unlike traditional chemotherapy, this medicine works by helping the immune system identify and destroy cancer cells. Darzalex Faspro specifically targets a protein called CD38 found on multiple myeloma cells, leading to their destruction and slowing disease progression. It is commonly prescribed either alone or in combination with other anti-cancer medicines, depending on the stage of the disease and previous treatments.
This medication requires careful medical supervision as it can affect blood cell counts and may reactivate dormant infections such as hepatitis B. Patients receiving Darzalex Faspro are closely monitored for infusion-related reactions and changes in blood test results to ensure safe and effective treatment.
Darzalex Faspro 1800mg Injection is used for:
It may be prescribed as monotherapy or combined with other cancer treatments based on individual clinical needs.
Darzalex Faspro works by binding to CD38, a protein highly expressed on multiple myeloma cells. Once attached, it activates the immune system to destroy these cancer cells through multiple immune pathways. This targeted action helps reduce tumor burden, slow disease progression, and improve treatment response while minimizing damage to healthy cells.
Side Effects of Darzalex Faspro 1800mg Injection
Like all medications, Darzalex Faspro 1800mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Darzalex Faspro 1800mg Injection is administered only by a trained healthcare professional in a hospital or clinical setting. The dose, frequency, and duration of treatment are determined by the doctor based on disease severity, previous treatments, and overall health. Patients are monitored during and after administration for possible reactions. Self-administration is strictly not allowed.
The safety of Darzalex Faspro during breastfeeding has not been clearly established. Breastfeeding mothers should consult their doctor to carefully assess potential risks before starting or continuing treatment.
Alcohol consumption may increase the risk of drowsiness, fatigue, or other side effects while receiving Darzalex Faspro. It is advisable to limit or avoid alcohol and discuss safe consumption with your healthcare provider.
Inform your doctor if you have asthma, chronic obstructive pulmonary disease (COPD), or any other respiratory conditions, as Darzalex Faspro may increase the risk of breathing-related reactions.
This medicine may cause dizziness, fatigue, or reduced alertness. Avoid driving or operating heavy machinery until you know how your body responds to the treatment.
Darzalex Faspro should be used during pregnancy only if absolutely necessary, as it may cause harm to the unborn baby. Women of childbearing potential are advised to use effective contraception during treatment and continue it for at least 3 months after the final dose.
Darzalex Faspro is an immunotherapy, not chemotherapy. It targets the CD38 protein on multiple myeloma cells and activates the immune system to destroy cancer cells while minimizing damage to healthy cells.
Yes, Darzalex Faspro may be used as a first-line or subsequent treatment depending on disease stage, prior therapies, and overall patient health, as determined by the oncologist.
Yes. Darzalex Faspro can interfere with blood typing and cross-matching tests. Patients should inform healthcare providers and blood banks before receiving any blood transfusions.
Patients with past hepatitis B infection must inform their doctor before treatment, as Darzalex Faspro may reactivate the virus and requires close monitoring throughout therapy.
Yes. Darzalex Faspro may be used long-term under strict medical supervision. Treatment duration depends on response, tolerability, and disease progression, with regular follow-ups required.
| Active ingredient | Daratumumab |
| Pharmacologic class | Monoclonal Antibody |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
